Morgan Creek-Exos Active SPAC Arbitrage ETF (CSH)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Morgan Creek-Exos Active SPAC Arbitrage ETF (CSH) trades at $25.63 with AI Score 44/100 (Grade C). Morgan Creek-Exos Active SPAC Arbitrage ETF (CSH) focuses on investing in special purpose acquisition companies (SPACs). Market cap: $8.32M, Sector: Financial services.
Price live · AI analysis from Mar 16, 2026Analyst Coverage for CSH: CSH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CSH against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
CSH: the 1 perspectives are evenly split.
How is this calculated? →Morgan Creek-Exos Active SPAC Arbitrage ETF (CSH) Financial Services Profile
Morgan Creek-Exos Active SPAC Arbitrage ETF (CSH) is a non-diversified fund specializing in pre-combination SPAC investments, targeting arbitrage opportunities within the U.S. market. With at least 80% of its net assets allocated to SPAC units, CSH seeks returns through mergers, acquisitions, or reorganizations involving blank check companies.
What Is the Investment Thesis for CSH?
The Morgan Creek-Exos Active SPAC Arbitrage ETF (CSH) presents a targeted investment vehicle for those seeking exposure to the SPAC market. The fund's strategy of investing at least 80% of its net assets in pre-combination SPACs aims to capture potential gains before a merger or acquisition is announced. The fund's non-diversified nature allows for concentrated bets on specific SPACs, potentially amplifying returns. Key to the investment thesis is the ability of the fund's management to identify and capitalize on arbitrage opportunities within the SPAC market. The success of CSH hinges on the expertise in evaluating SPACs, predicting successful mergers, and managing the risks associated with this specialized investment strategy. However, the non-diversified approach also amplifies risk if SPACs in the portfolio underperform or fail to find suitable merger targets.
Based on FMP financials and quantitative analysis
CSH Key Highlights
- CSH invests primarily in units of U.S.-listed SPACs, providing exposure to potential merger and acquisition activity.
- At least 80% of CSH's net assets are allocated to pre-combination SPACs, focusing on early-stage investment opportunities.
- CSH is a non-diversified fund, allowing for concentrated positions in specific SPACs.
- The fund seeks to capitalize on arbitrage opportunities within the SPAC market.
- CSH's performance is dependent on the success of SPACs in finding and completing mergers or acquisitions.
Who Are CSH's Competitors?
CSH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AMNA ETRACS Alerian Midstream Energy Index ETN | $53.58 | -3.51% | $8.48M | 44 |
| CBTG Cabot Growth ETF | $14.75 | -0.07% | $8.60M | 44 |
| EEMD AAM S&P Emerging Markets High Dividend Value ETF | $20.09 | +0.02% | $8.54M | 44 |
| EUCG Euclid Capital Growth ETF | $19.98 | +0.65% | $8.19M | 44 |
| FUT ProShares Managed Futures Strategy ETF | $41.93 | +0.13% | $8.17M | 44 |
| NXDT NexPoint Diversified Real Estate Trust | $5.53 | +3.08% | $285.77M | 73 |
| GENB Generate Biomedicines, Inc. | $17.03 | -2.18% | $2.18B | 72 |
| SII Sprott Inc. | $118.11 | +2.72% | $3.05B | 71 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CSH's Key Strengths?
- Focus on pre-combination SPACs allows for early-stage investment.
- Active management seeks to capitalize on arbitrage opportunities.
- Non-diversified approach allows for concentrated positions.
- Expertise in navigating the complexities of the SPAC market.
What Are CSH's Weaknesses?
- Non-diversified nature increases risk exposure.
- Performance is highly dependent on the success of SPAC mergers.
- Vulnerable to changes in SPAC market sentiment and regulations.
- Limited historical performance data due to the relatively new nature of the fund.
What Could Drive CSH Stock Higher?
- Potential mergers or acquisitions by SPACs in the portfolio could drive positive returns.
- Active management of the portfolio to capitalize on arbitrage opportunities.
- Growth in the SPAC market providing new investment opportunities.
What Are the Key Risks for CSH?
- Insider selling — insiders were net sellers of roughly $14.4M recently.
- Regulatory changes impacting SPAC structures and operations.
- Market volatility and economic downturns affecting SPAC valuations.
- Non-diversified nature increases risk exposure to individual SPAC performance.
- Failure of SPACs to find suitable merger targets.
What Are the Growth Opportunities for CSH?
- Expansion of SPAC Market: The continued growth and evolution of the SPAC market present ongoing opportunities for CSH. As more companies choose to go public via SPAC mergers, the fund can expand its investment universe and potentially identify new arbitrage opportunities. The timeline for this growth is dependent on overall market conditions and regulatory developments, but the SPAC market is expected to remain an active part of the IPO landscape.
- Increased Investor Interest in Alternative Investments: As investors seek diversification and alternative sources of returns, interest in specialized investment strategies like SPAC arbitrage may increase. CSH is positioned to benefit from this trend by offering a targeted approach to SPAC investing. The market size for alternative investments is substantial, and CSH can capture a portion of this market by demonstrating consistent performance and attracting investors seeking exposure to the SPAC market.
- Development of New SPAC Structures: The SPAC market is constantly evolving, with new structures and features being introduced. CSH can adapt its investment strategy to take advantage of these innovations, potentially enhancing returns and mitigating risks. The timeline for the development of new SPAC structures is uncertain, but CSH's active management approach allows it to respond quickly to changes in the market.
- Strategic Partnerships and Alliances: CSH can explore strategic partnerships with other financial institutions or investment firms to expand its reach and access new investment opportunities. These partnerships can provide access to deal flow, research, and distribution channels, enhancing CSH's competitive position. The timeline for forming strategic partnerships is dependent on finding suitable partners and negotiating mutually beneficial agreements.
- Enhanced Risk Management Techniques: By implementing advanced risk management techniques, CSH can improve its ability to navigate the volatility of the SPAC market and protect investor capital. This includes developing sophisticated models for evaluating SPACs, monitoring market conditions, and hedging against potential losses. The timeline for implementing enhanced risk management techniques is ongoing, as CSH continuously seeks to improve its processes and adapt to changing market conditions.
What Opportunities Does CSH Have?
- Expansion of the SPAC market provides new investment opportunities.
- Increased investor interest in alternative investments.
- Development of new SPAC structures and features.
- Strategic partnerships to expand reach and access to deal flow.
What Threats Does CSH Face?
- Increased competition in the SPAC market.
- Regulatory changes impacting SPAC structures and operations.
- Market volatility and economic downturns.
- Failure of SPACs to find suitable merger targets.
What Are CSH's Competitive Advantages?
- Expertise in SPAC Market: Deep understanding of SPAC structures, dynamics, and investment opportunities.
- Active Management: Ability to identify and capitalize on arbitrage opportunities through active portfolio management.
- Focus on Pre-Combination SPACs: Specialization in early-stage SPAC investments, potentially capturing higher returns.
- Non-Diversified Approach: Flexibility to concentrate investments in specific SPACs with high potential.
What Does CSH Do?
The Morgan Creek-Exos Active SPAC Arbitrage ETF (CSH) is designed to provide investors exposure to the special purpose acquisition company (SPAC) market. Founded with the objective of capitalizing on the unique dynamics of SPACs, CSH invests primarily in units consisting of common stock, warrants, and rights of U.S.-listed SPACs. These SPACs are essentially blank check companies created to raise capital through an initial public offering (IPO) with the intention of merging with or acquiring one or more operating businesses. CSH's strategy focuses on pre-combination SPACs, allocating at least 80% of its net assets to this segment. This approach allows the fund to participate in the potential upside of SPACs before they complete a merger or acquisition. The fund is non-diversified, meaning it can invest a larger portion of its assets in a smaller number of investments compared to a diversified fund. This strategy can potentially lead to higher returns but also carries greater risk. The fund operates under normal market conditions, actively managing its portfolio to take advantage of arbitrage opportunities within the SPAC market. By investing in SPAC units, CSH aims to benefit from the price discrepancies that may arise between the unit components (common stock, warrants, and rights) and the underlying value of the potential target company.
What Products and Services Does CSH Offer?
- Invests primarily in units of U.S.-listed special purpose acquisition companies (SPACs).
- Focuses on pre-combination SPACs, allocating at least 80% of net assets to this segment.
- Aims to capitalize on arbitrage opportunities within the SPAC market.
- Actively manages its portfolio to take advantage of price discrepancies between SPAC unit components.
- Seeks to benefit from mergers, acquisitions, reorganizations, or similar business combinations involving SPACs.
- Operates as a non-diversified fund, allowing for concentrated positions in specific SPACs.
How Does CSH Make Money?
- Generates returns through investments in SPAC units, including common stock, warrants, and rights.
- Profits from the successful completion of mergers or acquisitions by SPACs in its portfolio.
- Capitalizes on arbitrage opportunities arising from price discrepancies between SPAC unit components.
- Actively manages its portfolio to optimize returns and mitigate risks.
What Industry Does CSH Operate In?
The asset management industry is undergoing significant transformation, driven by factors such as increasing demand for specialized investment strategies and the growing popularity of ETFs. The SPAC market has experienced periods of rapid growth and increased scrutiny, with regulatory changes and market volatility impacting investor sentiment. CSH operates within this dynamic environment, offering a focused approach to SPAC investing. The fund's success depends on its ability to navigate the complexities of the SPAC market and deliver returns in a competitive landscape.
Who Are CSH's Key Customers?
- Institutional investors seeking exposure to the SPAC market.
- Sophisticated investors looking for alternative investment strategies.
- Investors seeking potential high returns through SPAC arbitrage.
- Investors comfortable with the risks associated with non-diversified investments.
How Morgan Creek-Exos Active SPAC Arbitrage ETF Is Valued
Relative to its peer group, CSH's quantitative score of 44/100 is roughly in line with the peer average of 44/100.
Net sellingInsider Activity
The most recent 12 insider filings for Morgan Creek-Exos Active SPAC Arbitrage ETF break down as 10 sales and 2 purchases. On net that is roughly 450K shares disposed (about $14.4M), a signal worth weighing alongside the fundamentals.
CSH Financials
Bull Case vs Bear Case
Bull Case
- Focus on pre-combination SPACs allows for early-stage investment.
- Active management seeks to capitalize on arbitrage opportunities.
- Non-diversified approach allows for concentrated positions.
- Expertise in navigating the complexities of the SPAC market.
Bear Case
- Non-diversified nature increases risk exposure.
- Performance is highly dependent on the success of SPAC mergers.
- Vulnerable to changes in SPAC market sentiment and regulations.
- Limited historical performance data due to the relatively new nature of the fund.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
CSH Latest News
-
Chartwell Retirement Residences (CSH.UN:CA) Shareholder/Analyst Call Transcript
All Articles on Seeking Alpha · Jun 18, 2026
-
Cenit AG (XTER:CSH) Q1 2026 Earnings Call Highlights: Strong Organic Growth and AI-Driven Success
Yahoo! Finance: CSH News · Jun 17, 2026
-
Chartwell Retirement Residences (CSH.UN:CA) Q1 2026 Earnings Call Transcript
seekingalpha.com · May 8, 2026
CSH Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CSH.
Price Targets
Wall Street price target analysis for CSH.
CSH MoonshotScore
What does this score mean?
The MoonshotScore rates CSH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
Chartwell Retirement Residences (CSH.UN:CA) Shareholder/Analyst Call Transcript
Cenit AG (XTER:CSH) Q1 2026 Earnings Call Highlights: Strong Organic Growth and AI-Driven Success
Chartwell Retirement Residences (CSH.UN:CA) Q1 2026 Earnings Call Transcript
CSH Financial Services Stock FAQ
What does Morgan Creek-Exos Active SPAC Arbitrage ETF do?
The Morgan Creek-Exos Active SPAC Arbitrage ETF (CSH) is a specialized investment fund that focuses on capitalizing on opportunities within the special purpose acquisition company (SPAC) market. CSH primarily invests in units of U.S.-listed SPACs before they complete a merger or acquisition. By allocating at least 80% of its net assets to pre-combination SPACs, CSH aims to benefit from the potential upside as these blank check companies seek to merge with operating businesses. The fund's active management seeks to identify and exploit arbitrage opportunities that arise from price discrepancies between the unit components, offering investors a targeted approach to SPAC investing.
What are the main risks for CSH?
The Morgan Creek-Exos Active SPAC Arbitrage ETF (CSH) faces several risks inherent to its investment strategy and the SPAC market. The fund's non-diversified nature means that its performance is highly dependent on the success of a limited number of SPACs. Regulatory changes impacting SPAC structures and operations could negatively affect the fund's investment opportunities. Market volatility and economic downturns could lead to declines in SPAC valuations. Additionally, there is a risk that SPACs in the portfolio may fail to find suitable merger targets, resulting in losses for the fund. Investors should carefully consider these risks before investing in CSH.
How sensitive is CSH to changes in the SPAC market sentiment?
CSH is highly sensitive to changes in SPAC market sentiment due to its focused investment strategy. Negative sentiment towards SPACs, driven by factors such as regulatory scrutiny, poor performance of post-merger companies, or broader market corrections, can significantly impact the fund's performance. A decline in investor confidence can lead to lower valuations for SPAC units, reduced deal flow, and increased redemptions, all of which can negatively affect CSH's returns. The fund's active management seeks to mitigate these risks, but its concentrated exposure to the SPAC market makes it vulnerable to shifts in market sentiment.
What is CSH's strategy for managing risks associated with SPAC mergers and acquisitions?
CSH employs an active management strategy to mitigate risks associated with SPAC mergers and acquisitions. This includes conducting thorough due diligence on SPACs and their potential merger targets, monitoring market conditions and regulatory developments, and actively managing the portfolio to capitalize on arbitrage opportunities. The fund also utilizes risk management techniques such as hedging and diversification within the SPAC universe to reduce exposure to individual SPACs. By carefully evaluating SPACs and their merger prospects, CSH aims to minimize the risk of investing in deals that are unlikely to be successful or that may result in losses for the fund.
What are the key factors to evaluate for CSH?
Morgan Creek-Exos Active SPAC Arbitrage ETF (CSH) holds an AI score of 44/100 (low). Not financial advice.
How frequently does CSH data refresh on this page?
CSH prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CSH's recent stock price performance?
Morgan Creek-Exos Active SPAC Arbitrage ETF (CSH) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on pre-combination SPACs allows for early-stage investment. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CSH overvalued or undervalued right now?
Valuing Morgan Creek-Exos Active SPAC Arbitrage ETF (CSH) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis pending for CSH, limiting the depth of some insights.
- Performance data may be limited due to the relatively new nature of the fund.
- The SPAC market is subject to regulatory changes and market volatility.